The binding mechanism of a peptidic cyclic serine protease inhibitor

Journal of Molecular Biology

Volumn 412, Issue 2, 2011, Pages 235-250

  Jiang, Longguang ^a,b   Svane, Anna S P ^a   Sørensen, Hans Peter ^a   Jensen, Jan K ^a   Hosseini, Masood ^a,c   Chen, Zhuo ^a,b   Weydert, Caroline ^a   Nielsen, Jakob T ^a   Christensen, Anni ^a   Yuan, Cai ^a,b   Jensen, Knud J ^a,c   Nielsen, Niels Chr ^a   Malmendal, Anders ^a   Huang, Mingdong ^a,b   Andreasen, Peter A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cancer; competitive inhibition; fibrinolysis

Indexed keywords

4 AMINOBENZAMIDINE; AMINO ACID; PLASMINOGEN ACTIVATOR INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; UPAIN 1; UROKINASE;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CONFORMATION; CRYSTAL STRUCTURE; ISOTHERMAL TITRATION CALORIMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE; THERMODYNAMICS; X RAY;

EID: 80052022147     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.07.028     Document Type: Article

References (40)

1. Branden C., and Tooze J. Introduction to Protein Structure 1991 Garland Publishing, Inc New York
2. Hedstrom L. Serine protease mechanism and specificity Chem. Rev. 102 2002 4501 4524
3. Drag M., and Salvesen G.S. Emerging principles in protease-based drug discovery Nat. Rev. Drug. Discov. 9 2010 690 701
4. Rockway T.W., Nienaber V., and Giranda V.L. Inhibitors of the protease domain of urokinase-type plasminogen activator Curr. Pharm. Des. 8 2002 2541 2558 (Pubitemid 35331529)
5. Krook M., Lindbladh C., Eriksen J.A., and Mosbach K. Selection of a cyclic nonapeptide inhibitor to α-chymotrypsin using a phage display peptide library Mol. Diversity 3 1997 149 159 (Pubitemid 127507548)
6. Dennis M.S., Eigenbrot C., Skelton N.J., Ultsch M.H., Santell L., and Dwyer M.A. Peptide exosite inhibitors of factor VIIa as anticoagulants Nature 404 2000 465 470 (Pubitemid 30186881)
7. Wu P., Leinonen J., Koivunen E., Lankinen H., and Stenman U.H. Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity Eur. J. Biochem. 267 2000 6212 6220
8. Heinis C., Rutherford T., Freund S., and Winter G. Phage-encoded combinatorial chemical libraries based on bicyclic peptides Nat. Chem. Biol. 5 2009 502 507
9. Hekim C., Leinonen J., Narvanen A., Koistinen H., Zhu L., and Koivunen E. Novel peptide inhibitors of human kallikrein 2 J. Biol. Chem. 281 2006 12555 12560 (Pubitemid 43855343)
10. Andersen L.M., Wind T., Hansen H.D., and Andreasen P.A. A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue Biochem. J. 412 2008 447 457 (Pubitemid 351846410)
11. Hansen M., Wind T., Blouse G.E., Christensen A., Petersen H.H., and Kjelgaard S. A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition J. Biol. Chem. 280 2005 38424 38437 (Pubitemid 43853740)
12. Andreasen P.A., Egelund R., and Petersen H.H. The plasminogen activation system in tumor growth, invasion, and metastasis Cell Mol. Life Sci. 57 2000 25 40 (Pubitemid 30105328)
13. Hildenbrand R., Allgayer H., Marx A., and Stroebel P. Modulators of the urokinase-type plasminogen activation system for cancer Expert Opin. Invest. Drugs 19 2010 641 652
14. Zhao G., Yuan C., Wind T., Huang Z., Andreasen P.A., and Huang M. Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1 J. Struct. Biol. 160 2007 1 10 (Pubitemid 47405230)
15. Ellis V., Behrendt N., and Dano K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor J. Biol. Chem. 266 1991 12752 12758 (Pubitemid 21907159)
16. Dunitz J.D. Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions Chem. Biol. 2 1995 709 712
17. Sharp K. Entropy-enthalpy compensation: fact or artifact? Protein Sci. 10 2001 661 667 (Pubitemid 32221155)
18. Janssen B.J., Halff E.F., Lambris J.D., and Gros P. Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition J. Biol. Chem. 282 2007 29241 29247 (Pubitemid 350043342)
19. Ogura K., Shiga T., Yokochi M., Yuzawa S., Burke T.R. Jr., and Inagaki F. Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor J. Biomol. NMR 42 2008 197 207
20. Pan B., Li B., Russell S.J., Tom J.Y., Cochran A.G., and Fairbrother W.J. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor J. Mol. Biol. 316 2002 769 787 (Pubitemid 34729253)
21. Andrews M.J., McInnes C., Kontopidis G., Innes L., Cowan A., Plater A., and Fischer P.M. Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes Org. Biomol. Chem. 2 2004 2735 2741
22. Luckett S., Garcia R.S., Barker J.J., Konarev A.V., Shewry P.R., Clarke A.R., and Brady R.L. High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds J. Mol. Biol. 290 1999 525 533 (Pubitemid 29324836)
23. 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant J. Mol. Biol. 311 2001 579 591 (Pubitemid 32816591)
24. Skelton N.J., Russell S., de Sauvage F., and Cochran A.G. Amino acid determinants of β-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library J. Mol. Biol. 316 2002 1111 1125 (Pubitemid 34729228)
25. Barazza A., Gotz M., Cadamuro S.A., Goettig P., Willem M., and Steuber H. Macrocyclic statine-based inhibitors of BACE-1 ChemBioChem 8 2007 2078 2091 (Pubitemid 350220758)
26. Spraggon G., Phillips C., Nowak U.K., Ponting C.P., Saunders D., and Dobson C.M. The crystal structure of the catalytic domain of human urokinase-type plasminogen activator Structure 3 1995 681 691
27. Olson S.T., Bock P.E., Kvassman J., Shore J.D., Lawrence D.A., Ginsburg D., and Bjork I. Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes J. Biol. Chem. 270 1995 30007 30017
28. Petersen H.H., Hansen M., Schousboe S.L., and Andreasen P.A. Localisation of epitopes for monoclonal anti-urokinase-type plasminogen activator antibodies. Relationship between epitope localization and effects of antibodies on molecular interactions of the enzyme Eur. J. Biochem. 268 2001 4430 4439 (Pubitemid 32862852)
29. Rogana E., Nelson D.L., and Mares-Guia M. Characterization of the ultraviolet absorption spectra of para-substituted derivatives of benzamidine J. Am. Chem. Soc. 97 1975 6844 6848
30. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326 (Pubitemid 27085611)
31. CCP4 The CCP4 suite: programs for protein crystallography Acta Crystallogr., Sect. D: Biol. Crystallogr. 50 1994 760 763
32. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132 (Pubitemid 41742764)
33. Schrodinger L.L.C. The PyMOL Molecular Graphics System, Version 1.3r1 2010 http://www.pymol.org
34. Morikis D., Assa-Munt N., Sahu A., and Lambris J.D. Solution structure of Compstatin, a potent complement inhibitor Protein Sci. 7 1998 619 627 (Pubitemid 28130884)
35. Pallaghy P.K., He W., Jimenez E.C., Olivera B.M., and Norton R.S. Structures of the contryphan family of cyclic peptides. Role of electrostatic interactions in cis-trans isomerism Biochemistry 39 2000 12845 12852
36. Goddard T.D., and Kneller D.G. SPARKY 3 2002 University of California San Francisco
37. Neuhaus D., and Williamson M.P. The Nuclear Overhauser Effect in Structural and Conformational Analysis 1989 VCJ Publishers Inc. New York
38. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., and Grosse-Kunstleve R.W. Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr., Sect. D: Biol. Crystallogr. 54 1998 905 921
39. Nilges M., Gronenborn A.M., Brunger A.T., and Clore G.M. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2 Protein Eng. 2 1988 27 38
40. Stein E.G., Rice L.M., and Brunger A.T. Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation J. Magn. Reson. 124 1997 154 164 (Pubitemid 127451396)